Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pseudomonas aeruginosa: Recent Advances in Vaccine Development
Matthew Killough, Aoife M. Rodgers, Rebecca J. Ingram
Vaccines (2022) Vol. 10, Iss. 7, pp. 1100-1100
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics
Stephen Wood, Timothy M. Kuzel, Sasha H. Shafikhani
Cells (2023) Vol. 12, Iss. 1, pp. 199-199
Open Access | Times Cited: 127
Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies
Ahmed Elfadadny, Rokaia F. Ragab, Maha Alharbi, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 30
The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria
Kanwal Khalid, Chit Laa Poh
Vaccines (2023) Vol. 11, Iss. 7, pp. 1264-1264
Open Access | Times Cited: 34
Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa
Xingyun Wang, Cong Liu, Nino Rcheulishvili, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 32
Antibiotic Resistance in Patients with Cystic Fibrosis: Past, Present, and Future
Evanthia Perikleous, Despoina Gkentzi, Aris Bertzouanis, et al.
Antibiotics (2023) Vol. 12, Iss. 2, pp. 217-217
Open Access | Times Cited: 30
Polyclonal anti-whole cell IgY passive immunotherapy shields against P. aeruginosa-induced acute pneumonia and burn wound infections in murine models
Tooba Sadat Ahmadi, Bahador Behrouz, Seyed Latif Mousavi Gargari
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Anti-quorum sensing potential of selenium nanoparticles against LasI/R, RhlI/R, and PQS/MvfR in Pseudomonas aeruginosa: a molecular docking approach
Kanak Raj Kanak, Regina Sharmila Dass, Archana Pan
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 17
Glycoconjugate vaccines against antimicrobial resistant pathogens
Charlotte Sorieul, Marta Dolce, Maria Rosaria Romano, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 1055-1078
Open Access | Times Cited: 16
Enhanced protective efficacy of an OprF/PcrV bivalent DNA vaccine against Pseudomonas aeruginosa using a hydrogel delivery system
Yating Zhang, Linxia Tian, Xuan Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116264-116264
Open Access | Times Cited: 5
The Impact of Antimicrobial Resistance in Cystic Fibrosis
Antonio Vitiello, Francesco Blasi, Michela Sabbatucci, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1711-1711
Open Access | Times Cited: 4
Recent trends and challenges to overcome Pseudomonas aeruginosa infections
Alessandra Ammazzalorso, Arianna Granese, Barbara De Filippis
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 6, pp. 493-509
Closed Access | Times Cited: 4
Decoding antibiotic resistance in Pseudomonas aeruginosa: Embracing innovative therapies beyond conventional antibiotics
Nomita Gupta, Kanchan Chauhan, Garima Singh, et al.
The Microbe (2025), pp. 100233-100233
Open Access
Inovirus-Encoded Peptides Induce Specific Toxicity in Pseudomonas aeruginosa
Juehua Weng, Yunxue Guo, Jiayu Gu, et al.
Viruses (2025) Vol. 17, Iss. 1, pp. 112-112
Open Access
State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens
Matteo Ridelfi, Giulio Pierleoni, V. Fonseca, et al.
Seminars in Respiratory and Critical Care Medicine (2025)
Closed Access
Pseudomonas aeruginosa Vaccine Development: Lessons, Challenges, and Future Innovations
Rebeca Santamarina-Fernández, Víctor Fuentes-Valverde, Alis Silva-Rodríguez, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2012-2012
Open Access
Whole proteome-integrated and vaccinomics-based next generation mRNA vaccine design against Pseudomonas aeruginosa-A hierarchical subtractive proteomics approach
Sara Aiman, Abbas Ahmad, Abdul Malik, et al.
International Journal of Biological Macromolecules (2025), pp. 142627-142627
Closed Access
Immunization with lytic polysaccharide monooxygenase CbpD induces protective immunity against Pseudomonas aeruginosa pneumonia
Fatemeh Askarian, Chih‐Ming Tsai, Gabriele Cordara, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 30
Open Access | Times Cited: 10
Metagenomic next-generation sequencing of bronchoalveolar lavage fluid from children with severe pneumonia in pediatric intensive care unit
Caiyan Zhang, Tingyan Liu, Yixue Wang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 9
Efficacy of a Pseudomonas aeruginosa serogroup O9 vaccine
Dina A. Moustafa, Antonio DiGiandomenico, Vishnu Raghuram, et al.
Infection and Immunity (2023) Vol. 91, Iss. 12
Open Access | Times Cited: 9
A Semisynthetic Oligomannuronic Acid-Based Glycoconjugate Vaccine against Pseudomonas aeruginosa
Yiyue Zhang, Xiaotong Wang, Youling Liang, et al.
ACS Central Science (2024) Vol. 10, Iss. 8, pp. 1515-1523
Open Access | Times Cited: 3
Beyond Antibiotics: What the Future Holds
Payam Benyamini
Antibiotics (2024) Vol. 13, Iss. 10, pp. 919-919
Open Access | Times Cited: 3
Extracellular Vesicles of Pseudomonas: Friends and Foes
Tania Henríquez, Chiara Falciani
Antibiotics (2023) Vol. 12, Iss. 4, pp. 703-703
Open Access | Times Cited: 8
Development of innovative multi-epitope mRNA vaccine against Pseudomonas aeruginosa using in silico approaches
Maryam Asadinezhad, Saeed Khoshnood, Parisa Asadollahi, et al.
Briefings in Bioinformatics (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 7
Navigating ESKAPE Pathogens: Considerations and Caveats for Animal Infection Models Development
Haojie Yu, Yongchang Xu, Saber İmani, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 7, pp. 2336-2355
Open Access | Times Cited: 2
Phylogenetic Tracing of Evolutionarily Conserved Zonula Occludens Toxin Reveals a “High Value” Vaccine Candidate Specific for Treating Multi-Strain Pseudomonas aeruginosa Infections
Payam Benyamini
Toxins (2024) Vol. 16, Iss. 6, pp. 271-271
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top